| Efficacy and safety of dupilumab in glucocorticoid-dependent severe asthma KF Rabe, P Nair, G Brusselle, JF Maspero, M Castro, L Sher, H Zhu, ... New England journal of medicine 378 (26), 2475-2485, 2018 | 1044 | 2018 |
| Metabolic network failures in Alzheimer's disease: A biochemical road map JB Toledo, M Arnold, G Kastenmüller, R Chang, RA Baillie, X Han, ... Alzheimer's & Dementia 13 (9), 965-984, 2017 | 393 | 2017 |
| Enteric microbiome metabolites correlate with response to simvastatin treatment R Kaddurah-Daouk, RA Baillie, H Zhu, ZB Zeng, MM Wiest, UT Nguyen, ... PLoS One 6 (10), e25482, 2011 | 219 | 2011 |
| Alterations in metabolic pathways and networks in Alzheimer’s disease R Kaddurah-Daouk, H Zhu, S Sharma, M Bogdanov, SG Rozen, ... Translational psychiatry 3 (4), e244-e244, 2013 | 199 | 2013 |
| Glycine and a Glycine Dehydrogenase (GLDC) SNP as Citalopram/Escitalopram Response Biomarkers in Depression: Pharmacometabolomics‐Informed … Y Ji, S Hebbring, H Zhu, GD Jenkins, J Biernacka, K Snyder, M Drews, ... Clinical Pharmacology & Therapeutics 89 (1), 97-104, 2011 | 174 | 2011 |
| Lipidomic analysis of variation in response to simvastatin in the Cholesterol and Pharmacogenetics Study R Kaddurah-Daouk, RA Baillie, H Zhu, ZB Zeng, MM Wiest, UT Nguyen, ... Metabolomics 6, 191-201, 2010 | 137 | 2010 |
| Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: a proof of concept R Kaddurah-Daouk, SH Boyle, W Matson, S Sharma, S Matson, H Zhu, ... Translational psychiatry 1 (7), e26-e26, 2011 | 134 | 2011 |
| Lipidomics reveals early metabolic changes in subjects with schizophrenia: effects of atypical antipsychotics J McEvoy, RA Baillie, H Zhu, P Buckley, MS Keshavan, HA Nasrallah, ... PloS one 8 (7), e68717, 2013 | 133 | 2013 |
| Metabolomics Reveals Amino Acids Contribute to Variation in Response to Simvastatin Treatment M Trupp, H Zhu, WR Wikoff, RA Baillie, ZB Zeng, PD Karp, O Fiehn, ... PLoS ONE 7 (7), e38386, 2012 | 119 | 2012 |
| TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: pharmacometabolomics-informed pharmacogenomics M Gupta, D Neavin, D Liu, J Biernacka, D Hall-Flavin, WV Bobo, MA Frye, ... Molecular psychiatry 21 (12), 1717-1725, 2016 | 106 | 2016 |
| Pharmacometabolomics of response to sertraline and to placebo in major depressive disorder–possible role for methoxyindole pathway H Zhu, MB Bogdanov, SH Boyle, W Matson, S Sharma, S Matson, ... PloS one 8 (7), e68283, 2013 | 93 | 2013 |
| Purine pathway implicated in mechanism of resistance to aspirin therapy: pharmacometabolomics‐informed pharmacogenomics LM Yerges‐Armstrong, S Ellero‐Simatos, A Georgiades, H Zhu, J Lewis, ... Clinical pharmacology & Therapeutics 94 (4), 525-532, 2013 | 91 | 2013 |
| Pharmacometabolomic mapping of early biochemical changes induced by sertraline and placebo R Kaddurah-Daouk, MB Bogdanov, WR Wikoff, H Zhu, SH Boyle, ... Translational Psychiatry 3 (1), e223, 2013 | 89 | 2013 |
| Pharmacometabolomics reveals racial differences in response to atenolol treatment WR Wikoff, RF Frye, H Zhu, Y Gong, S Boyle, E Churchill, ... PloS one 8 (3), e57639, 2013 | 88 | 2013 |
| Cerebrospinal Fluid Metabolome in Mood Disorders-Remission State has a Unique Metabolic Profile R Kaddurah-Daouk, P Yuan, SH Boyle, W Matson, Z Wang, ZB Zeng, ... Scientific Reports 2, 2012 | 79 | 2012 |
| Impaired plasmalogens in patients with schizophrenia R Kaddurah-Daouk, J McEvoy, R Baillie, H Zhu, JK Yao, VL Nimgaonkar, ... Psychiatry research 198 (3), 347-352, 2012 | 76 | 2012 |
| Pharmacometabolomics reveals that serotonin is implicated in aspirin response variability S Ellero‐Simatos, JP Lewis, A Georgiades, LM Yerges‐Armstrong, ... CPT: pharmacometrics & systems pharmacology 3 (7), 1-9, 2014 | 70 | 2014 |
| Beta-defensin 1, aryl hydrocarbon receptor and plasma kynurenine in major depressive disorder: metabolomics-informed genomics D Liu, B Ray, DR Neavin, J Zhang, AP Athreya, JM Biernacka, WV Bobo, ... Translational psychiatry 8 (1), 10, 2018 | 67 | 2018 |
| Merging pharmacometabolomics with pharmacogenomics using ‘1000 Genomes’ single-nucleotide polymorphism imputation: selective serotonin reuptake inhibitor response pharmacogenomics R Abo, S Hebbring, Y Ji, H Zhu, ZB Zeng, A Batzler, GD Jenkins, ... Pharmacogenetics and genomics 22 (4), 247-253, 2012 | 66 | 2012 |
| Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients S Bhattacharyya, AT Ahmed, M Arnold, D Liu, C Luo, H Zhu, ... Translational psychiatry 9 (1), 173, 2019 | 62 | 2019 |
Oliver FiehnUC DavisVerified email at ucdavis.edu
